Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief

(MedPage Today) — Among rheumatoid arthritis (RA) patients responding to upadacitinib (Rinvoq) or adalimumab, those receiving the former had significantly less residual pain with treatment, according to a post-hoc analysis of phase III trial data…

Source link : https://www.medpagetoday.com/rheumatology/arthritis/119344

Author :

Publish date : 2026-01-08 21:25:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief

‘They’ve Just Gotten It Wrong’: Vaccine Shift Raises Fears of Hepatitis A, B Surges

AMA Urges Congress to Make Telehealth Flexibilities Permanent

Related Posts

Dual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence

Are there ‘forever chemicals’ in your floor cleaner?

Botox, Trulicity, and 13 Other Drugs Selected for Medicare Price Negotiation

Charities Warn UK Youth Are ‘Europe’s Unhappiest’

The Rear View: How Glute Shape Predicts Diabetes Risk

We’re getting closer to growing a brain in a lab dish

Dual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence

Are there ‘forever chemicals’ in your floor cleaner?

Botox, Trulicity, and 13 Other Drugs Selected for Medicare Price Negotiation

Charities Warn UK Youth Are ‘Europe’s Unhappiest’

The Rear View: How Glute Shape Predicts Diabetes Risk

We’re getting closer to growing a brain in a lab dish

Stroke Now Ranks Fourth as a Leading Cause of Death

Indoor Ice Air a Health Concern Ahead of 2026 Olympics

Categories

Archives